$7.87
0.030.38%
At close: -
$7.87
0.000.00%
After Hours: 4:00 PM EDT
bluebird bio reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of bluebird bio using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-14 | $-6.20 | $-7.00 | 11.4 % |
Q2 | 2024-09-27 | $-8.40 | $-7.60 | -10.5 % |
Q1 | 2024-09-13 | $-7.20 | $-8.80 | 18.2 % |
Q3 | 2023-11-07 | $-13.20 | $-13.40 | 1.49 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-14 | $10.61M | $18.68M | -43.2 % |
Q2 | 2024-09-27 | $16.10M | $16.88M | -4.61 % |
Q1 | 2024-09-13 | $18.57M | $19.55M | -5.00 % |
Q3 | 2023-11-07 | $12.39M | $13.31M | -6.90 % |
bluebird bio (BLUE) is scheduled to report earnings on March 25, 2025. The last reported earnings were for reported on November 14, 2024 for Q3.
The Actual EPS was $-6.20, which beat the estimate of $-7.00.
The Actual Revenue was $10.6M, which missed the estimate of $18.7M.
Browse earnings estimates, EPS, and revenue on all stocks.